The MedChemComm UK-China Symposium took place last month. The Symposium, organised by MedChemComm and the RSC International Programme, took place on the 22nd November at the Chemistry Centre in London.
Professor Zhenjun Yang presenting at the symposium
A great line-up of speakers gave presentations on topics from across the broad spectrum of medicinal chemistry. Dr Jason Wong (Roche R&D Centre, China) started off the day with his work on the development of a novel epigenetic modulator for hepatocellular carcinoma. Jason was followed by MedChemComm Editorial Board member Dr Mark Bunnage (Pfizer, UK), who talked about small molecule modulators of stem cells, and then Professor Zhenjun Yang (Peking University, China) reporting chemically modified siRNAs and their biological properties.
Dr Rich Soll (WuXi AppTec, China) opened up after lunch describing collaborative medicinal chemistry at WuXi AppTec, followed by Professor Paul Wyatt (University of Dundee, UK) describing some of his recent work developing antiparasitic leads. Rounding off the day were Professor Fa-Jun Nan (Shanghai Institute of Materia Medica, CAS, China), speaking about a hepatitis B inhibitor derived from a marine natural product, and Professor Chris Abell (University of Cambridge, UK), who spoke about anti-tuberculosis natural products.
Dr Richard Pike, CEO of the Royal Society of Chemistry and Professor Jingkang Shen, representing the Chinese Pharmaceutical Association, exchange gifts
Many thanks to the organising committee, the symposium sponsors – Pfizer and AstraZeneca – and everyone who attended.
Why not contribute to the success of MedChemComm by submitting your article today?
